These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1202 related articles for article (PubMed ID: 17963732)

  • 1. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
    Arai T; Mackenzie IR; Hasegawa M; Nonoka T; Niizato K; Tsuchiya K; Iritani S; Onaya M; Akiyama H
    Acta Neuropathol; 2009 Feb; 117(2):125-36. PubMed ID: 19139911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
    Nakashima-Yasuda H; Uryu K; Robinson J; Xie SX; Hurtig H; Duda JE; Arnold SE; Siderowf A; Grossman M; Leverenz JB; Woltjer R; Lopez OL; Hamilton R; Tsuang DW; Galasko D; Masliah E; Kaye J; Clark CM; Montine TJ; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2007 Sep; 114(3):221-9. PubMed ID: 17653732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.
    Kasanuki K; Iseki E; Kondo D; Fujishiro H; Minegishi M; Sato K; Katsuse O; Hino H; Kosaka K; Arai H
    Neurosci Lett; 2014 May; 569():68-73. PubMed ID: 24704327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
    Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW
    Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
    Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.
    Hart de Ruyter FJ; Evers MJAP; Morrema THJ; Dijkstra AA; den Haan J; Twisk JWR; de Boer JF; Scheltens P; Bouwman FH; Verbraak FD; Rozemuller AJ; Hoozemans JJM
    Acta Neuropathol; 2024 Aug; 148(1):24. PubMed ID: 39160362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontotemporal lobar degeneration and dementia with Lewy bodies: clinicopathological issues associated with antemortem diagnosis.
    Yokota O
    Psychogeriatrics; 2009 Jun; 9(2):91-102. PubMed ID: 19604332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
    Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
    Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pathology in primary progressive language and speech disorders.
    Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
    Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
    Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
    Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
    Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
    J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.